1188PIdentification of prognostic and predictive factors for durvalumab efficacy by modeling of tumor response and overall survival (OS) in patients with non-small cell lung cancer (NSCLC). (23rd October 2018) - Zheng, Y; Narwal, R; Jin, C; Baverel, P; Gupta, A; Mukhopadhyay, P; Higgs, B W; Roskos, L